Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and Arginine Restriction in Colorectal Cancer
NCT00578721Phase 2Completed
- Sponsor
- University of California, Irvine
- Start
- Sep 2008
- Primary completion
- Nov 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of aspirin in colorectal cancer (CRC), sponsored by University of California, Irvine. Primary endpoint: Rectal Tissue Putrescine Reduction at 12 weeks. Started Sep 2008; status: completed.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00578721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00578721.